INNOVADERM CRO IS NOW INDERO.

Exploring the Intersections: Dermatology and Rheumatology Insights

Indero

Indero

Team of Experts

Author picture

Indero is proud to spotlight an insightful discussion featuring Dr. Juan Ovalles, Senior Director, Rheumatology, and Dr. Jasmina Jankicevic, Chief Medical and Scientific Officer. In this webinar, the two leaders unpack the growing convergence between dermatology and rheumatology, exploring how shared biological pathways can drive smarter, more efficient clinical development strategies.

As chronic inflammatory diseases continue to reveal overlapping mechanisms, understanding these intersections is becoming essential. Dr. Ovalles and Dr. Jankicevic examine the common immunological drivers, including TNF‑alpha, IL‑17, and IL‑23, and explain how they influence both therapeutic approaches and trial design across multiple indications.The conversation also highlights key distinctions between dermatologic and rheumatologic conditions; insights that are critical for crafting precise protocols, selecting meaningful endpoints, and tailoring patient‑centric strategies.

👇🔊 Listen to the full discussion to explore the evolving relationship between dermatology and rheumatology and gain a deeper understanding of the pathways shaping the next generation of clinical development.

Planning an upcoming rheumatology trial?

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.